Description
bpc 157 tb 500 kpv ghk cu ghk-cu 50mg tb4 10mg 10mg 50mg, BPC-157 TB-500 10mg, Size:1000 mcg/ml Kenalog Injection Size:250ml AOD-9604 (2 mg Vial)
AOD-9604 (2 mg Vial) Dosage & Reconstitution
It should be noted that BPC-157 is contraindicated in those with cancer
Kenalog Injection
Size:250ml
BPC-157 Mechanism: The VEGF/Akt/eNOS Chain and Controlled Angiogenesis BPC-157 (Body Protection Compound 157) is a fragment of the gastric protein BPC, first isolated and characterized by Predrag Sikiric's team at the University of Zagreb in 1993